IceCure Medical Q3 2024 Earnings Report $1.26 +0.02 (+1.20%) As of 12:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Earnings HistoryForecast IceCure Medical EPS ResultsActual EPS-$0.08Consensus EPS -$0.07Beat/MissMissed by -$0.01One Year Ago EPSN/AIceCure Medical Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AIceCure Medical Announcement DetailsQuarterQ3 2024Date11/26/2024TimeBefore Market OpensConference Call ResourcesICCM Earnings History IceCure Medical Earnings HeadlinesIceCure Medical files for approval of ProSense Cryoablation System in ChinaJanuary 28 at 6:58 AM | markets.businessinsider.comIceCure Files for Regulatory Approval of ProSense® Cryoablation System in ChinaJanuary 27, 2025 | prnewswire.comForced out of retirement by these trades You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changed Now, I get it… that sounds like the corny intro to a made-for-TV movie. But in reality, these trades did absolutely transform the way I look at the market… and I’m not the only one! When I showed Roger Scott my 77 trade real-money track record, with an 80% win rate and multiple 100% winners in 5 days, he practically forced me out of retirement!January 31, 2025 | WealthPress (Ad)Comparing iCAD (NASDAQ:ICAD) & IceCure Medical (NASDAQ:ICCM)January 25, 2025 | americanbankingnews.comIceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense Sales for 2024 in North AmericaJanuary 13, 2025 | finanznachrichten.deIceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North AmericaJanuary 13, 2025 | prnewswire.comSee More IceCure Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like IceCure Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IceCure Medical and other key companies, straight to your email. Email Address About IceCure MedicalIceCure Medical (NASDAQ:ICCM), a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.View IceCure Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? Upcoming Earnings NXP Semiconductors (2/3/2025)Palantir Technologies (2/3/2025)PayPal (2/3/2025)Mitsubishi UFJ Financial Group (2/3/2025)Amgen (2/4/2025)Advanced Micro Devices (2/4/2025)Alphabet (2/4/2025)Alphabet (2/4/2025)Mondelez International (2/4/2025)Apollo Global Management (2/4/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
